To further investigate whether TMEM106B is involved in the clinical progression of Alzheimer’s disease, we turned to the cross-sectional ROSMAP cohort, which includes cognitively unimpaired individuals and individuals with mild cognitive impairment (MCI) and Alzheimer’s disease (AD). The gene discussed is TMEM106B; the disease is early-onset autosomal dominant Alzheimer disease.